Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Neural Regulation01:37

Neural Regulation

39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rewards bias self-evaluations of ability.

Communications psychology·2025
Same author

A Microfluidic Strategy to Capture Antigen-Specific High-Affinity B Cells.

Advanced nanobiomed research·2025
Same author

A molecular glue for PRKN/parkin.

Autophagy·2024
Same author

Activation of parkin by a molecular glue.

Nature communications·2024
Same author

Enhanced binding of guanylated poly(A) RNA by the LaM domain of LARP1.

RNA biology·2024
Same author

Parkinson's disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons.

Neuron·2023

Related Experiment Video

Updated: Jun 17, 2025

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

11.9K

Naturally occurring hyperactive variants of human parkin.

Tahrima Saiha Huq1,2,3, Jean Luo1,2,4, Rayan Fakih1,2

  • 1Department of Biochemistry, McGill University, Montréal, Canada.

Communications Biology
|August 8, 2024
PubMed
Summary

Researchers investigated naturally occurring parkin variants to understand early-onset Parkinson's disease (PD) genetics. This study validates hyperactive parkin variants, crucial for developing new PD therapies targeting mitochondrial quality control.

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.1K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

5.9K

Related Experiment Videos

Last Updated: Jun 17, 2025

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

11.9K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.1K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

5.9K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • Parkinson's disease (PD) is the second most common neurodegenerative disorder.
  • Genetic mutations in the PRKN gene (encoding parkin) cause early-onset PD.
  • Parkin and PINK1 regulate mitochondrial quality control via mitophagy.

Purpose of the Study:

  • To validate the in vitro hyperactivity of naturally occurring parkin variants.
  • To compare the activity of these variants with wild-type parkin and a known hyperactive variant (W403A).
  • To investigate the impact of mutations in the parkin ACT (activating element) on enzyme activity.

Main Methods:

  • In vitro biochemical assays to measure parkin E3 ligase activity.
  • Characterization of wild-type and mutant parkin variants, including naturally occurring hyperactive forms.
  • Analysis of parkin ACT domain mutations.

Main Results:

  • Several naturally occurring parkin variants exhibit enhanced E3 ligase activity in vitro.
  • The activity levels of these variants were quantified and compared to controls.
  • Mutations in the parkin ACT domain influence enzyme activity.

Conclusions:

  • This study validates the hyperactive nature of specific parkin variants in vitro.
  • Findings advance the understanding of parkin variant pathogenicity in early-onset Parkinson's disease.
  • This research is a foundational step towards designing therapeutic molecules to enhance parkin activity for PD treatment.